Vitamin D and its effects on glucose homeostasis, cardiovascular function and immune function

Hormone Research in Paediatrics

Volumn 81, Issue 6, 2014, Pages 363-378

  El Fakhri, N ^a   McDevitt, H ^a,b   Shaikh, M G ^a   Halsey, C ^c   Ahmed, S F ^a  

^a UNIVERSITY OF GLASGOW   (United Kingdom)

^b SOUTHERN GENERAL HOSPITAL   (United Kingdom)

^c UNIVERSITY OF GLASGOW   (United Kingdom)

Author keywords

Cardiovascular function; Extraskeletal benefits; Glucose homeostasis; Immune function; Vitamin D

Indexed keywords

C REACTIVE PROTEIN; GLUCOSE; HIGH DENSITY LIPOPROTEIN; LOW DENSITY LIPOPROTEIN; TRIACYLGLYCEROL; VASCULOTROPIN; VITAMIN D; 25-HYDROXYVITAMIN D; COLECALCIFEROL; ERGOCALCIFEROL;

ADAPTIVE IMMUNITY; ANTIGEN PRESENTATION; CARDIOVASCULAR FUNCTION; CARDIOVASCULAR SYSTEM; CHILDHOOD; CORRELATIONAL STUDY; GLUCOSE HOMEOSTASIS; HUMAN; IMMUNE RESPONSE; INNATE IMMUNITY; INTERVENTION STUDY; KNOWLEDGE; MOLECULAR MECHANICS; OBSERVATIONAL STUDY; PRIORITY JOURNAL; REVIEW; VASCULAR SMOOTH MUSCLE; VITAMIN D DEFICIENCY; VITAMIN SUPPLEMENTATION; ADOLESCENT; ANALOGS AND DERIVATIVES; ANIMAL; CHILD; DRUG EFFECTS; FEMALE; HOMEOSTASIS; IMMUNITY; INFANT; MALE; METABOLISM; PATHOPHYSIOLOGY; PHYSIOLOGY; PRESCHOOL CHILD; RISK FACTOR; AUTOIMMUNE DISEASE; B LYMPHOCYTE; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CELL FUNCTION; CHILD DEVELOPMENT; CLINICAL TRIAL (TOPIC); DIABETES MELLITUS; GLUCOSE INTOLERANCE; GLUCOSE TOLERANCE; INSULIN RELEASE; INSULIN RESISTANCE; INSULIN SENSITIVITY; INSULIN SYNTHESIS; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; PANCREAS CELL; RANDOMIZED CONTROLLED TRIAL (TOPIC); VITAMIN DEFICIENCY;

ADAPTIVE IMMUNITY; ADOLESCENT; ANIMALS; CARDIOVASCULAR PHYSIOLOGICAL PHENOMENA; CARDIOVASCULAR SYSTEM; CHILD; CHILD, PRESCHOOL; CHOLECALCIFEROL; ERGOCALCIFEROLS; FEMALE; GLUCOSE; HOMEOSTASIS; HUMANS; IMMUNITY; IMMUNITY, INNATE; INFANT; MALE; RISK FACTORS; VITAMIN D; VITAMIN D DEFICIENCY;

EID: 84904392297     PISSN: 16632818     EISSN: 16632826     Source Type: Journal    
DOI: 10.1159/000357731     Document Type: Review

References (162)

1. Holick MF: Resurrection of vitamin D deficiency and rickets. J Clin Invest 2006; 116: 2062-2072.
2. Holick MF: Vitamin D deficiency. N Engl J Med 2007; 357: 266-281.
3. Henry HL: Regulation of vitamin D metabolism. Best Pract Res Clin Endocrinol Metab 2011; 25: 531-541.
4. Nagpal S, Na SQ, Rathnachalam R: Noncalcemic actions of vitamin D receptor ligands. Endocr Rev 2005; 26: 662-687.
5. Institute of Medicine (IOM): Dietary Reference Intakes for Calcium and Vitamin D. Washington, The National Academies Press, 2011.
6. Holick MF, Binkley NC, Bischoff-Ferrari HA, Gordon CM, Hanley DA, Heaney RP, Murad MH, Weaver CM: Evaluation, treatment, and prevention of vitamin D deficiency: an endocrine society clinical practice guideline. J Clin Endocrinol Metab 2011; 96: 1911-1930.
7. Ross AC, Manson JE, Abrams SA, Aloia JF, Brannon PM, Clinton SK, Durazo-Arvizu RA, Gallagher JC, Gallo RL, Jones G, Kovacs CS, Mayne ST, Rosen CJ, Shapses SA: The 2011 report on dietary reference intakes for calcium and vitamin D from the Institute of Medicine: what clinicians need to know. J Clin Endocrinol Metab 2011; 96: 53-58.
8. Misra M, Pacaud D, Petryk A, Collett-Solberg PF, Kappy M: Vitamin D deficiency in children and its management: review of current knowledge and recommendations. Pediatrics 2008; 122: 398-417.
9. Rosen CJ, Abrams SA, Aloia JF, Brannon PM, Clinton SK, Durazo-Arvizu RA, Gallagher JC, Gallo RL, Jones G, Kovacs CS, Manson JE, Mayne ST, Ross AC, Shapses SA, Taylor CL: IOM committee members respond to endocrine society vitamin D guideline. J Clin Endocrinol Metab 2012; 97: 1146-1152.
10. Schneider LE, Schedl HP, McCain T, Haussler MR: Experimental diabetes reduces circulating 1,25-dihydroxyvitamin D in rat. Science 1977; 196: 1452-1454.
11. Scragg R, Holdaway I, Singh V, Metcalf P, Baker J, Dryson E: Serum 25-hydroxyvitamin D3 levels decreased in impaired glucose-tolerance and diabetes-mellitus. Diabetes Res Clin Pract 1995; 27: 181-188.
12. Behall KM, Scholfield DJ, Hallfrisch JG, Kelsay JL, Reiser S: Seasonal variation in plasma glucose and hormone levels in adult men and women. Am J Clin Nutr 1984; 40: 1352-1356.
13. Bland R, Markovic D, Hills CE, Hughes SV, Chan SLF, Squires PE, Hewison M: Expression of 25-hydroxyvitamin D3 -1α-hydroxylase in pancreatic islets. J Steroid Biochem Mol Biol 2004; 89-90: 121-125.
14. Johnson JA, Grande JP, Roche PC, Kumar R: Immunohistochemical localization of the 1,25(OH)2 D3 receptor and calbindin D-28k in human and rat pancreas. Am J Physiol 1994; 267:E356-E360.
15. Maestro B, Davila N, Carranza MC, Calle C: Identification of a vitamin D response element in the human insulin receptor gene promoter. J Steroid Biochem Mol Biol 2003; 84: 223-230.
16. Zeitz U, Weber K, Soegiarto DW, Wolf E, Balling R, Erben RG: Impaired insulin secretory capacity in mice lacking a functional vitamin D receptor. FASEB J 2003; 17: 509-511.
17. Maestro B, Molero S, Bajo S, Davila N, Calle C: Transcriptional activation of the human insulin receptor gene by 1,25-dihydroxyvitamin D3. Cell Biochem Funct 2002; 20: 227-232.
18. Lee S, Clark SA, Gill RK, Christakos S: 1,25-Dihydroxyvitamin-D3 and pancreatic cell function: vitamin-D receptors, gene expression, and insulin secretion. Endocrinology 1994; 134: 1602-1610.
19. Riachy R, Vandewalle B, Conte JK, Moerman E, Sacchetti P, Lukowiak B, Gmyr V, Bouckenooghe T, Dubois M, Pattou F: 1,25-Dihydroxyvitamin D3 protects RINm5F and human islet cells against cytokine-induced apoptosis: implication of the antiapoptotic protein A20. Endocrinology 2002; 143: 4809-4819.
20. Riachy R, Vandewalle B, Moerman E, Belaich S, Lukowiak B, Gmyr V, Muharram G, Conte J, Pattou F: 1,25-Dihydroxyvitamin D3 protects human pancreatic islets against cytokineinduced apoptosis via down-regulation of the Fas receptor. Apoptosis 2006; 11: 151-159.
21. Kawashima H, Castro A: Effect of 1α-hydroxyvitamin D3 on the glucose and calcium-metabolism in genetic obese mice. Res Commun Chem Pathol Pharmacol 1981; 33: 155-161.
22. Zhou QG, Hou FF, Guo ZJ, Liang M, Wang GB, Zhang X: 1,25-Dihydroxyvitamin D improved the free fatty-acid-induced insulin resistance in cultured C2C12 cells. Diabetes Metab Res Rev 2008; 24: 459-464.
23. Maestro B, Campion J, Davila N, Calle C: Stimulation by 1,25-dihydroxyvitamin D3 of insulin receptor expression and insulin responsiveness for glucose transport in U-937 human promonocytic cells. Endocr J 2000; 47: 383-391.
24. McCarty MF: Vitamin D, parathyroid hormone, and insulin sensitivity. Am J Clin Nutr 2004; 80: 1451-1452.
25. Sadeghi K, Wessner B, Laggner U, Ploder M, Tamandl D, Friedl J, Zugel U, Steinmeyer A, Pollak A, Roth E, Boltz-Nitulescu G, Spittler A: Vitamin D3 down-regulates monocyte TLR expression and triggers hyporesponsiveness to pathogen-associated molecular patterns. Eur J Immunol 2006; 36: 361-370.
26. Baker RG, Hayden MS, Ghosh S: NF-κB, inflammation, and metabolic disease. Cell Metab 2011; 13: 11-22.
27. Teegarden D, Donkin SS: Vitamin D: Emerging new roles in insulin sensitivity. Nutr Res Rev 2009; 22: 82-92.
28. Orwoll E, Riddle M, Prince M: Effects of vitamin D on insulin and glucagon secretion in non-insulin-dependent diabetes-mellitus. Am J Clin Nutr 1994; 59: 1083-1087.
29. Boucher BJ, Mannan N, Noonan K, Hales CN, Evans SJ: Glucose intolerance and impairment of insulin secretion in relation to vitamin- D deficiency in East London Asians. Diabetologia 1995; 38: 1239-1245.
30. Baynes KCR, Boucher BJ, Feskens EJ, Kromhout D: Vitamin D, glucose tolerance and insulinaemia in elderly men. Diabetologia 1997; 40: 344-347.
31. Chiu KC, Chu A, Go VL, Saad MF: Hypovitaminosis D is associated with insulin resistance and cell dysfunction. Am J Clin Nutr 2004; 79: 820-825.
32. Kamycheva E, Jorde R, Figenschau Y, Haug E: Insulin sensitivity in subjects with secondary hyperparathyroidism and the effect of a low serum 25-hydroxyvitamin D level on insulin sensitivity. J Endocrinol Invest 2007; 30: 126-132.
33. Scragg R, Sowers M, Bell C: Serum 25-hydroxyvitamin D, diabetes, and ethnicity in the Third National Health and Nutrition Examination Survey. Diabetes Care 2004; 27: 2813-2818.
34. Forouhi NG, Luan J, Cooper A, Boucher BJ, Wareham NJ: Baseline serum 25-hydroxy vitamin D is predictive of future glycemic status and insulin resistance - the medical research council Ely prospective study 1990-2000. Diabetes 2008; 57: 2619-2625.
35. Song Y, Wang L, Pittas AG, Del Gobbo LC, Zhang C, Manson JE, Hu FB: Blood 25- hydroxyvitamin D levels and incident type 2 diabetes: a meta-analysis of prospective studies. Diabetes Care 2013; 36: 1422-1428.
36. Reinehr T, de Sousa G, Alexy U, Kersting M, Andler W: Vitamin D status and parathyroid hormone in obese children before and after weight loss. Eur J Endocrinol 2007; 157: 225-232.
37. Smotkin-Tangorra M, Purushothaman R, Gupta A, Nejati G, Anhalt H, Ten S: Prevalence of vitamin D insufficiency in obese children and adolescents. J Pediatr Endocrinol Metab 2007; 20: 817-823.
38. Poomthavorn P, Saowan S, Mahachoklertwattana P, Chailurkit L, Khlairit P: Vitamin D status and glucose homeostasis in obese children and adolescents living in the tropics. Int J Obes 2012; 36: 491-495.
39. Olson ML, Maalouf NM, Oden JD, White PC, Hutchison MR: Vitamin D deficiency in obese children and its relationship to glucose homeostasis. J Clin Endocrinol Metab 2012; 97: 279-285.
40. Roth CL, Elfers C, Kratz M, Hoofnagle AN: Vitamin D deficiency in obese children and its relationship to insulin resistance and adipokines. J Obes 2011; 2011: 495101.
41. Nsiah-Kumi PA, Erickson JM, Beals JL, Ogle EA, Whiting M, Brushbreaker C, Borgeson CD, Qiu F, Yu F, Larsen JL: Vitamin D insufficiency is associated with diabetes risk in native American children. Clin Pediatr (Phila) 2012; 51: 146-153.
42. Gedik O, Akalin S: Effects of vitamin-D deficiency and repletion on insulin and glucagon secretion in man. Diabetologia 1986; 29: 142-145.
43. Inomata S, Kadowaki S, Yamatani T, Fukase M, Fujita T: Effect of 1α(OH)-vitamin D 3 on insulin-secretion in diabetes mellitus. Bone Miner 1986; 1: 187-192.
44. Ljunghall S, Lind L, Lithell H, Skarfors E, Selinus I, Sorensen OH, Wide L: Treatment with 1α-hydroxycholecalciferol in middle-aged men with impaired glucose-tolerance - a prospective randomized double-blind-study. Acta Med Scand 1987; 222: 361-367.
45. Nyomba BL, Auwerx J, Bormans V, Peeters TL, Pelemans W, Reynaert J, Bouillon R, Vantrappen G, De Moor P: Pancreatic-secretion in man with subclinical vitamin-D deficiency. Diabetologia 1986; 29: 34-38.
46. Zofkova I, Stolba P: Effect of calcitriol and trifluoperazine on glucose stimulated cell function in healthy humans. Exp Clin Endocrinol 1990; 96: 185-191.
47. Grimnes G, Figenschau Y, Almas B, Jorde R: Vitamin D, insulin secretion, sensitivity, and lipids results from a case-control study and a randomized controlled trial using hyperglycemic clamp technique. Diabetes 2011; 60: 2748-2757.
48. Tai K, Need AG, Horowitz M, Chapman IM: Glucose tolerance and vitamin D: effects of treating vitamin D deficiency. Nutrition 2008; 24: 950-956.
49. Von Hurst PR, Stonehouse W, Coad J: Vitamin D supplementation reduces insulin resistance in South Asian women living in New Zealand who are insulin resistant and vitamin D deficient - a randomised, placebo-controlled trial. Br J Nutr 2010; 103: 549-555.
50. Mitri J, Dawson-Hughes B, Hu FB, Pittas AG: Effects of vitamin D and calcium supplementation on pancreatic cell function, insulin sensitivity, and glycemia in adults at high risk of diabetes: the Calcium and Vitamin D for Diabetes Mellitus (CaDDM) randomized controlled trial. Am J Clin Nutr 2011; 94: 486-494.
51. Belenchia AM, Tosh AK, Hillman LS, Peterson CA: Correcting vitamin D insufficiency improves insulin sensitivity in obese adolescents: a randomized controlled trial. Am J Clin Nutr 2013; 97: 774-781.
52. Rose G: Cold weather and ischaemic heart disease. Br J Prev Soc Med 1966; 20: 97-100.
53. Fleck A: Latitude and ischemic heart disease. Lancet 1989; 1: 613.
54. Martins D, Wolf M, Pan D, Zadshir A, Tareen N, Thadhani R, Felsenfeld A, Levine B, Mehrotra R, Norris K: Prevalence of cardiovascular risk factors and the serum levels of 25-hydroxyvitamin D in the United States - data from the Third National Health and Nutrition Examination Survey. Arch Intern Med 2007; 167: 1159-1165.
55. Awad AB, Alappat L, Valerio M: Vitamin D and metabolic syndrome risk factors: evidence and mechanisms. Crit Rev Food Sci Nutr 2012; 52: 103-112.
56. Anderson JL, Vanwoerkom RC, Horne BD, Bair TL, May HT, Lappe DL, Muhlestein JB: Parathyroid hormone, vitamin D, renal dysfunction, and cardiovascular disease: dependent or independent risk factors? Am Heart J 2011; 162: 331-339.
57. Li YC, Kong J, Wei MJ, Chen ZF, Liu SQ, Cao LP: 1,25-Dihydroxyvitamin D 3 is a negative endocrine regulator of the renin-angiotensin system. J Clin Invest 2002; 110: 229-238.
58. O'Connell TD, Berry JE, Jarvis AK, Somerman MJ, Simpson RU: 1,25-Dihydroxyvitamin D 3 regulation of cardiac myocyte proliferation and hypertrophy. Am J Physiol 1997; 272:H1751-H1758.
59. Carthy EP, Yamashita W, Hsu A, Ooi BS: 1,25-Dihydroxyvitamin D 3 and rat vascular smooth muscle cell growth. Hypertension 1989; 13: 954-959.
60. Borges ACR, Feres T, Vianna LM, Paiva TB: Effect of cholecalciferol treatment on the relaxant responses of spontaneously hypertensive rat arteries to acetylcholine. Hypertension 1999; 34: 897-901.
61. Ohsawa M, Koyama T, Yamamoto K, Hirosawa S, Kamei S, Kamiyama R: 1α,25- Dihydroxyvitamin D 3 and its potent synthetic analogs downregulate tissue factor and upregulate thrombomodulin expression in monocytic cells, counteracting the effects of tumor necrosis factor and oxidized LDL. Circulation 2000; 102: 2867-2872.
62. Dobnig H, Pilz S, Scharnagl H, Renner W, Seelhorst U, Wellnitz B, Kinkeldei J, Boehm BO, Weihrauch G, Maerz W: Independent association of low serum 25-hydroxyvitamin D and 1,25-dihydroxyvitamin D levels with all-cause and cardiovascular mortality. Arch Intern Med 2008; 168: 1340-1349.
63. Timms PM, Mannan N, Hitman GA, Noonan K, Mills PG, Syndercombe-Court D, Aganna E, Price CP, Boucher BJ: Circulating MMP-9, vitamin D and variation in the TIMP-1 response with VDR genotype: mechanisms for inflammatory damage in chronic disorders? QJM 2002; 95: 787-796.
64. Alvarez JA, Ashraf A: Role of vitamin D in insulin secretion and insulin sensitivity for glucose homeostasis. Int J Endocrinol 2010; 2010: 351385.
65. Andersson P, Rydberg E, Willenheimer R: Primary hyperparathyroidism and heart disease - a review. Eur Heart J 2004; 25: 1776-1787.
66. Foley RN, Parfrey PS, Harnett JD, Kent GM, Martin CJ, Murray DC, Barre PE: Clinical and echocardiographic disease in patients starting end-stage renal disease therapy. Kidney Int 1995; 47: 186-192.
67. Xiang W, Kong J, Chen SC, Cao LP, Qiao GL, Zheng W, Liu WH, Li XM, Gardner DG, Li YC: Cardiac hypertrophy in vitamin D receptor knockout mice: role of the systemic and cardiac renin-angiotensin systems. Am J Physiol Endocrinol Metab 2005; 288:E125- E132.
68. Resnick LM, Muller FB, Laragh JH: Calciumregulating hormones in essential hypertension - relation to plasma-renin activity and sodium-metabolism. Ann Intern Med 1986; 105: 649-654.
69. Lind L, Hanni A, Lithell H, Hvarfner A, Sorensen OH, Ljunghall S: Vitamin D is related to blood pressure and other cardiovascular risk factors in middle-aged men. Am J Hypertens 1995; 8: 894-901.
70. Weng S, Sprague JE, Oh J, Riek AE, Chin K, Garcia M, Bernal-Mizrachi C: Vitamin D deficiency induces high blood pressure and accelerates atherosclerosis in mice. PLoS One 2013; 8:e54625.
71. Puri S, Bansal DD, Uskokovic MR, Mac- Gregor RR: Induction of tissue plasminogen activator secretion from rat heart microvascular cells by fM 1,25(OH) 2 D 3. Am J Physiol Endocrinol Metab 2000; 278:E293-E301.
72. O'Connell TD, Berry JE, Jarvis AK, Somerman MJ, Simpson RU: 1,25-Dihydroxyvitamin D 3 regulation of cardiac myocyte proliferation and hypertrophy. Am J Physiol 1997; 272:H1751-H1758.
73. Nibbelink KA, Tishkoff DX, Hershey SD, Rahman A, Simpson RU: 1,25(OH) 2 -vitamin D 3 actions on cell proliferation, size, gene expression, and receptor localization, in the HL-1 cardiac myocyte. J Steroid Biochem Mol Biol 2007; 103: 533-537.
74. Bae S, Singh SS, Yu H, Lee JY, Cho BR, Kang PM: Vitamin D signaling pathway plays an important role in the development of heart failure after myocardial infarction. J Appl Physiol 2013; 114: 979-987.
75. Kendrick J, Targher G, Smits G, Chonchol M: 25-Hydroxyvitamin D deficiency is independently associated with cardiovascular disease in the Third National Health and Nutrition Examination Survey. Atherosclerosis 2009; 205: 255-260.
76. Marniemi J, Alanen E, Impivaara O, Seppanen R, Hakala P, Rajala T, Ronnemaa T: Dietary and serum vitamins and minerals as predictors of myocardial infarction and stroke in elderly subjects. Nutr Metab Cardiovasc Dis 2005; 15: 188-197.
77. Zhao G, Ford ES, Li C, Croft JB: Serum 25-hydroxyvitamin D levels and all-cause and cardiovascular disease mortality among US adults with hypertension: the NHANES linked mortality study. J Hypertens 2012; 30: 284-289.
78. Bhandari SK, Pashayan S, Liu ILA, Rasgon SA, Kujubu DA, Tom TY, Sim JJ: 25-hydroxyvitamin D levels and hypertension rates. J Clin Hypertens (Greenwich) 2011; 13: 170-177.
79. Giovannucci E, Liu Y, Hollis BW, Rimm EB: 25-Hydroxyvitamin D and risk of myocardial infarction in men - a prospective study. Arch Intern Med 2008; 168: 1174-1180.
80. Messenger W, Nielson CM, Li H, Beer T, Barrett- Connor E, Stone K, Shannon J: Serum and dietary vitamin D and cardiovascular disease risk in elderly men: a prospective cohort study. Nutr Metab Cardiovasc Dis 2012; 22: 856-863.
81. Dolinsky DH, Armstrong S, Mangarelli C, Kemper AR: The association between vitamin D and cardiometabolic risk factors in children: a systematic review. Clin Pediatr (Phila) 2013; 52: 210-223.
82. Reis JP, von Muehlen D, Miller ER III, Michos ED, Appel LJ: Vitamin D status and cardiometabolic risk factors in the United States adolescent population. Pediatrics 2009; 124: E371-E379.
83. Pacifico L, Anania C, Osborn JF, Ferraro F, Bonci E, Olivero E, Chiesa C: Low 25(OH)D 3 levels are associated with total adiposity, metabolic syndrome, and hypertension in Caucasian children and adolescents. Eur J Endocrinol 2011; 165: 603-611.
84. Kosecik M, Ertas T: Dilated cardiomyopathy due to nutritional vitamin D deficiency rickets. Pediatr Int 2007; 49: 397-399.
85. Olgun H, Ceviz N, Ozkan B: A case of dilated cardiomyopathy due to nutritional vitamin D deficiency rickets. Turk J Pediatr 2003; 45: 152-154.
86. Stricker H, Bianda FT, Guidicelli-Nicolosi S, Limoni C, Colucci G: Effect of a single, oral, high-dose vitamin D supplementation on endothelial function in patients with peripheral arterial disease: a randomised controlled pilot study. Eur J Vasc Endovasc Surg 2012; 44: 307-312.
87. Sugden JA, Davies JI, Witham MD, Morris AD, Struthers AD: Vitamin D improves endothelial function in patients with type 2 diabetes mellitus and low vitamin D levels. Diabet Med 2008; 25: 320-325.
88. Hsia J, Heiss G, Ren H, Allison M, Dolan NC, Greenland P, Heckbert SR, Johnson KC, Manson JE, Sidney S, Trevisan M: Calcium/ vitamin D supplementation and cardiovascular events. Circulation 2007; 115: 846-854.
89. LaCroix AZ, Kotchen J, Anderson G, Brzyski R, Cauley JA, Cummings SR, Gass M, Johnson KC, Ko M, Larson J, Manson JE, Stefanick ML, Wactawski-Wende J: Calcium plus vitamin D supplementation and mortality in postmenopausal women: the Women's Health Initiative calcium-vitamin D randomized controlled trial. J Gerontol A Biol Sci Med Sci 2009; 64: 559-567.
90. Elamin MB, Abu Elnour NO, Elamin KB, Fatourechi MM, Alkatib AA, Almandoz JP, Liu H, Lane MA, Mullan RJ, Hazem A, Erwin PJ, Hensrud DD, Murad MH, Montori VM: Vitamin D and cardiovascular outcomes: a systematic review and meta-analysis. J Clin Endocrinol Metab 2011; 96: 1931-1942.
91. Dong Y, Stallmann-Jorgensen IS, Pollock NK, Harris RA, Keeton D, Huang Y, Li K, Bassali R, Guo D-H, Thomas J, Pierce GL, White J, Holick MF, Zhu H: A 16-week randomized clinical trial of 2,000 international units daily vitamin D 3 supplementation in black youth: 25-hydroxyvitamin D, adiposity, and arterial stiffness. J Clin Endocrinol Metab 2010; 95: 4584-4591.
92. Ashraf AP, Alvarez JA, Gower BA, Saenz KH, McCormick KL: Associations of serum 25-hydroxyvitamin D and components of the metabolic syndrome in obese adolescent females. Obesity 2011; 19: 2214-2221.
93. Souberbielle J-C, Body J-J, Lappe JM, Plebani M, Shoenfeld Y, Wang TJ, Bischoff- Ferrari HA, Cavalier E, Ebeling PR, Fardellone P, Gandini S, Gruson D, Guerin AP, Heickendorff L, Hollis BW, Ish-Shalom S, Jean G, von Landenberg P, Largura A, Olsson T, Pierrot-Deseilligny C, Pilz S, Tincani A, Valcour A, Zittermann A: Vitamin D and musculoskeletal health, cardiovascular disease, autoimmunity and cancer: recommendations for clinical practice. Autoimmun Rev 2010; 9: 709-715.
94. Gepner AD, Ramamurthy R, Krueger DC, Korcarz CE, Binkley N, Stein JH: A prospective randomized controlled trial of the effects of vitamin D supplementation on cardiovascular disease risk. PLoS One 2012; 7:e36617.
95. Ross JR, Robertson EC, Tisdall FF: Effect of sunshine through window glass and fresh air on resistance to infection - experiments on animals. Am J Dis Child 1933; 45: 81-95.
96. Holick MF: Environmental factors that influence the cutaneous production of vitamin D. Am J Clin Nutr 1995; 61: 638S-645S.
97. Chan TY: Vitamin D deficiency and susceptibility to tuberculosis. Calcif Tissue Int 2000; 66: 476-478.
98. Kong J, Zhang Z, Musch MW, Ning G, Sun J, Hart J, Bissonnette M, Li YC: Novel role of the vitamin D receptor in maintaining the integrity of the intestinal mucosal barrier. Am J Physiol Gastrointest Liver Physiol 2008; 294:G208-G216.
99. Yin Z, Pintea V, Lin Y, Hammock BD, Watsky MA: Vitamin D enhances corneal epithelial barrier function. Invest Ophthalmol Vis Sci 2011; 52: 7359-7364.
100. Clairmont A, Tessmann D, Stock A, Nicolai S, Stahl W, Sies H: Induction of gap junctional intercellular communication by vitamin D in human skin fibroblasts is dependent on the nuclear vitamin D receptor. Carcinogenesis 1996; 17: 1389-1391.
101. Gniadecki R, Gajkowska B, Hansen M: 1,25-Dihydroxyvitamin D 3 stimulates the assembly of adherens junctions in keratinocytes: involvement of protein kinase C. Endocrinology 1997; 138: 2241-2248.
102. Palmer HG, Gonzalez-Sancho JM, Espada J, Berciano MT, Puig I, Baulida J, Quintanilla M, Cano A, de Herreros AG, Lafarga M, Munoz A: Vitamin D 3 promotes the differentiation of colon carcinoma cells by the induction of E-cadherin and the inhibition of catenin signaling. J Cell Biol 2001; 154: 369-387.
103. Yim S, Dhawan P, Ragunath C, Christakos S, Diamond G: Induction of cathelicidin in normal and CF bronchial epithelial cells by 1,25- dihydroxyvitamin D 3. J Cyst Fibros 2007; 6: 403-410.
104. Hertting O, Holm A, Luthje P, Brauner H, Dyrdak R, Jonasson AF, Wiklund P, Chromek M, Brauner A: Vitamin D induction of the human antimicrobial peptide cathelicidin in the urinary bladder. PloS One 2010; 5:e15580.
105. Weber G, Heilborn JD, Jimenez CIC, Hammarsjo A, Torma H, Stahle M: Vitamin D induces the antimicrobial protein hCAP18 in human skin. J Invest Dermatol 2005; 124: 1080-1082.
106. Gombart AF, Borregaard N, Koeffler HP: Human cathelicidin antimicrobial peptide (CAMP) gene is a direct target of the vitamin D receptor and is strongly up-regulated in myeloid cells by 1,25-dihydroxyvitamin D 3. FASEB J 2005; 19: 1067-1077.
107. Aung G, Niyonsaba F, Ushio H, Kajiwara N, Saito H, Ikeda S, Ogawa H, Okumura K: Catestatin, a neuroendocrine antimicrobial peptide, induces human mast cell migration, degranulation and production of cytokines and chemokines. Immunology 2011; 132: 527-539.
108. Chertov O, Michiel DF, Xu LL, Wang JM, Tani K, Murphy WJ, Longo DL, Taub DD, Oppenheim JJ: Identification of defensin-1, defensin-2, and CAP37/azurocidin as T-cell chemoattractant proteins released from interleukin- 8-stimulated neutrophils. J Biol Chem 1996; 271: 2935-2940.
109. Zughaier SM, Shafer WM, Stephens DS: Antimicrobial peptides and endotoxin inhibit cytokine and nitric oxide release but amplify respiratory burst response in human and murine macrophages. Cell Microbiol 2005; 7: 1251-1262.
110. Lai Y, Li D, Li C, Muehleisen B, Radek KA, Park HJ, Jiang Z, Li Z, Lei H, Quan Y, Zhang T, Wu Y, Kotol P, Morizane S, Hata TR, Iwatsuki K, Tang C, Gallo RL: The antimicrobial protein REG3A regulates keratinocyte proliferation and differentiation after skin injury. Immunity 2012; 37: 74-84.
111. Zhang J-Z, Maruyama K, Ono I, Kaneko F: Production and secretion of platelet-derived growth factor AB by cultured human keratinocytes: regulatory effects of phorbol 12-myristate 13-acetate, etretinate, 1,25-dihydroxyvitamin D3 , and several cytokines. J Dermatol (Tokyo) 1995; 22: 305-309.
112. Chandra G, Selvaraj P, Jawahar MS, Banurekha VV, Narayanan PR: Effect of vitamin D 3 on phagocytic potential of macrophages with live mycobacterium tuberculosis and lymphoproliferative response in pulmonary tuberculosis. J Clin Immunol 2004; 24: 249-257.
113. Adorini L, Penna G: Induction of tolerogenic dendritic cells by vitamin D receptor agonists. Handb Exp Pharmacol 2009; 188: 251-273.
114. Ferreira GB, van Etten E, Verstuyf A, Waer M, Overbergh L, Gysemans C, Mathieu C: 1,25-Dihydroxyvitamin D3 alters murine dendritic cell behaviour in vitro and in vivo. Diabetes Metab Res Rev 2011; 27: 933-941.
115. Penna G, Adorini L: 1α,25-Dihydroxyvitamin D3 inhibits differentiation, maturation, activation, and survival of dendritic cells leading to impaired alloreactive T-cell activation. J Immunol 2000; 164: 2405-2411.
116. Hewison M, Zehnder D, Chakraverty R, Adams JS: Vitamin D and barrier function: a novel role for extrarenal 1α-hydroxylase. Mol Cell Endocrinol 2004; 215: 31-38.
117. Von Essen MR, Kongsbak M, Schjerling P, Olgaard K, Odum N, Geisler C: Vitamin D controls T-cell antigen receptor signaling and activation of human T cells. Nat Immunol 2010; 11: 344-349.
118. Boonstra A, Barrat FJ, Crain C, Heath VL, Savelkoul HFJ, O'Garra A: 1α,25- Dihydroxyvitamin D3 has a direct effect on naive CD4 + T cells to enhance the development of Th2 cells. J Immunol 2001; 167: 4974-4980.
119. Baeke F, Korf H, Overbergh L, Verstuyf A, Thorrez L, Van Lommel L, Waer M, Schuit F, Gysemans C, Mathieu C: The vitamin D analog, TX527, promotes a human CD4 + CD25 high CD27 low regulatory T-cell profile and induces a migratory signature specific for homing to sites of inflammation. J Immunol 2011; 186: 132-142.
120. Prietl B, Pilz S, Wolf M, Tomaschitz A, Obermayer-Pietsch B, Graninger W, Pieber TR: Vitamin D supplementation and regulatory T cells in apparently healthy subjects: vitamin D treatment for autoimmune diseases? Isr Med Assoc J 2010; 12: 136-139.
121. Mosmann TR, Coffman RL: Th1 and TH2 cells different patterns of lymphokine secretion lead to different functional properties. Annu Rev Immunol 1989; 7: 145-173.
122. Mahon BD, Gordon SA, Cruz J, Cosman F, Cantorna MT: Cytokine profile in patients with multiple sclerosis following vitamin D supplementation. J Neuroimmunol 2003; 134: 128-132.
123. Staeva-Vieira TP, Freedman LP: 1,25-Dihydroxyvitamin D3 inhibits IFN and IL-4 levels during in vitro polarization of primary murine CD4 + T cells. J Immunol 2002; 168: 1181-1189.
124. Higashimoto Y, Ohata M, Nishio K, Iwamoto Y, Fujimoto H, Uetani K, Suruda T, Nakamura Y, Funasako M, Saijo N: 1α,25- Dihydroxyvitamin D3 and all- trans -retinoic acid inhibit the growth of a lung cancer cell line. Anticancer Res1996; 16: 2653-2659.
125. Chang SH, Chung Y, Dong C: Vitamin D suppresses Th17 cytokine production by inducing C/EBP homologous protein (CHOP) expression. J Biol Chem 2010; 285: 38751-38755.
126. Chen S, Sims GP, Chen XX, Gu YY, Chen S, Lipsky PE: Modulatory effects of 1,25-dihydroxyvitamin D3 on human B cell differentiation. J Immunol 2007; 179: 1634-1647.
127. Cantorna MT, Zhao J, Yang L: Symposium 3: Vitamin D and immune function: from pregnancy to adolescence vitamin D, invariant natural killer T cells and experimental autoimmune disease. Proc Nutr Soc 2012; 71: 62-66.
128. Camargo CA Jr, Ingham T, Wickens K, Thadhani R, Silvers KM, Epton MJ, Town GI, Pattemore PK, Espinola JA, Crane J: Cord-blood 25-hydroxyvitamin D levels and risk of respiratory infection, wheezing, and asthma. Pediatrics 2011; 127:E180-E187.
129. Muhe L, Lulseged S, Mason KE, Simoes EAF: Case-control study of the role of nutritional rickets in the risk of developing pneumonia in Ethiopian children. Lancet 1997; 349: 1801-1804.
130. Laaksi I, Ruohola JP, Tuohimaa P, Auvinen A, Haataja R, Pihlajamaki H, Ylikomi T: An association of serum vitamin D concentrations <40 nmol/l with acute respiratory tract infection in young Finnish men. Am J Clin Nutr 2007; 86: 714-717.
131. Gibney KB, MacGregor L, Leder K, Torresi J, Marshall C, Ebeling PR, Biggs BA: Vitamin D deficiency is associated with tuberculosis and latent tuberculosis infection in immigrants from sub-Saharan Africa. Clin Infect Dis 2008; 46: 443-446.
132. Ulitsky A, Ananthakrishnan AN, Naik A, Skaros S, Zadvornova Y, Binion DG, Issa M: Vitamin D deficiency in patients with inflammatory bowel disease: association with disease activity and quality of life. J Parenter Enteral Nutr 2011; 35: 308-316.
133. McDermott AM: The role of antimicrobial peptides at the ocular surface. Ophthalmic Res 2009; 41: 60-75.
134. Carretero M, Escamez MJ, Garcia M, Duarte B, Holguin A, Retamosa L, Jorcano JL, del Rio M, Larcher F: In vitro and in vivo wound healing-promoting activities of human cathelicidin LL-37. J Invest Dermatol 2008; 128: 223-236.
135. Di Nardo A, Yamasaki K, Dorschner RA, Lai Y, Gallo RL: Mast cell cathelicidin antimicrobial peptide prevents invasive group a streptococcus infection of the skin. J Immunol 2008; 180: 7565-7573.
136. Kaur I, Saraswat A, Kumar B: Comparison of calcipotriol and coal tar in conjunction with sun exposure in chronic plaque psoriasis: a pilot study. J Dermatol 2001; 28: 448-450.
137. Howell MD, Jones JF, Kisich KO, Streib JE, Gallo RL, Leung DYM: Selective killing of vaccinia virus by lL-37: implications for eczema vaccinatum. J Immunol 2004; 172: 1763-1767.
138. Asgari MM, Tang J, Warton ME, Chren M-M, Quesenberry CP Jr, Bikle D, Horst RL, Orentreich N, Vogelman JH, Friedman GD: Association of prediagnostic serum vitamin D levels with the development of basal cell carcinoma. J Invest Dermatol 2010; 130: 1438-1443.
139. Cantorna MT, Mahon BD: Mounting evidence for vitamin D as an environmental factor affecting autoimmune disease prevalence. Exp Biol Med 2004; 229: 1136-1142.
140. Cutolo M, Pizzorni C, Sulli A: Vitamin D endocrine system involvement in autoimmune rheumatic diseases. Autoimmun Rev 2011; 11: 84-87.
141. Munger KL, Zhang SM, O'Reilly E, Hernan MA, Olek MJ, Willett WC, Ascherio A: Vitamin D intake and incidence of multiple sclerosis. Neurology 2004; 62: 60-65.
142. Kamen DL, Cooper GS, Bouali H, Shaftman SR, Hollis BW, Gilkeson GS: Vitamin D deficiency in systemic lupus erythematosus. Autoimmun Rev 2006; 5: 114-117.
143. Stene LC, Joner G: Use of cod liver oil during the first year of life is associated with lower risk of childhood-onset type1 diabetes: a large, population-based, case-control study. Am J Clin Nutr 2003; 78: 1128-1134.
144. Jahnsen J, Falch JA, Mowinckel P, Aadland E: Vitamin D status, parathyroid hormone and bone mineral density in patients with inflammatory bowel disease. Scand J Gastroenterol 2002; 37: 192-199.
145. Bergman P, Norlin A-C, Hansen S, Rekha RS, Agerberth B, Bjorkhem-Bergman L, Ekstrom L, Lindh JD, Andersson J: Vitamin D3 supplementation in patients with frequent respiratory tract infections: a randomised and double-blind intervention study. BMJ open 2012; 2:e001663.
146. Murdoch DR, Slow S, Chambers ST, Jennings LC, Stewart AW, Priest PC, Florkowski CM, Livesey JH, Camargo CA Jr, Scragg R: Effect of vitamin D3 supplementation on upper respiratory tract infections in healthy adults: the VIDARIS randomized controlled trial. JAMA 2012; 308: 1333-1339.
147. Avenell A, Cook JA, Maclennan GS, Macpherson GC: Vitamin D supplementation to prevent infections: a sub-study of a randomised placebo-controlled trial in older people (RECORD trial, ISRCTN 51647438). Age Ageing 2007; 36: 574-577.
148. Salahuddin N, Ali F, Hasan Z, Rao N, Aqeel M, Mahmood F: Vitamin D accelerates clinical recovery from tuberculosis: results of the SUCCINCT study (Supplementary Cholecalciferol in Recovery from Tuberculosis). A randomized, placebo-controlled, clinical trial of vitamin D supplementation in patients with pulmonary tuberculosis'. BMC Infect Dis 2013; 13: 22.
149. Wejse C, Gomes VF, Rabna P, Gustafson P, Aaby P, Lisse IM, Andersen PL, Glerup H, Sodemann M: Vitamin D as supplementary treatment for tuberculosis a double-blind, randomized, placebo-controlled trial. Am J Respir Crit Care Med 2009; 179: 843-850.
150. Pozuelo-Moyano B, Benito-Leon J, Mitchell AJ, Hernandez-Gallego J: A systematic review of randomized, double-blind, placebocontrolled trials examining the clinical efficacy of vitamin D in multiple sclerosis. Neuroepidemiology 2013; 40: 147-153.
151. Urashima M, Segawa T, Okazaki M, Kurihara M, Wada Y, Ida H: Randomized trial of vitamin D supplementation to prevent seasonal influenza a in school children. Am J Clin Nutr 2010; 91: 1255-1260.
152. Camargo CA Jr, Ganmaa D, Frazier AL, Kirchberg FF, Stuart JJ, Kleinman K, Sumberzul N, Rich-Edwards JW: Randomized trial of vitamin D supplementation and risk of acute respiratory infection in Mongolia. Pediatrics 2012; 130:E561-E567.
153. Manaseki-Holland S, Qader G, Masher MI, Bruce J, Mughal MZ, Chandramohan D, Walraven G: Effects of vitamin D supplementation to children diagnosed with pneumonia in Kabul: a randomised controlled trial. Trop Med Int Health 2010; 15: 1148-1155.
154. Manaseki-Holland S, Maroof Z, Bruce J, Mughal MZ, Masher MI, Bhutta ZA, Walraven G, Chandramohan D: Effect on the incidence of pneumonia of vitamin D supplementation by quarterly bolus dose to infants in Kabul: a randomised controlled superiority trial. Lancet 2012; 379: 1419-1427.
155. Delvin EE, Lambert M, Levy E, O'Loughlin J, Mark S, Gray-Donald K,
156. Ford ES, Zhao G, Tsai J, Li C: Associations between concentrations of vitamin D and concentrations of insulin, glucose, and HbA 1c among adolescents in the United States. Diabetes Care 2011; 34: 646-648.
157. Kelly A, Brooks LJ, Dougherty S, Carlow DC, Zemel BS: A cross-sectional study of vitamin D and insulin resistance in children. Arch Dis Child 2010; 96: 447-452.
158. Patange AR, Valentini RP, Gothe MP, Du W, Pettersen MD: Vitamin D deficiency is associated with increased left ventricular mass and diastolic dysfunction in children with chronic kidney disease. Pediatr Cardiol 2013; 34: 536-542.
159. Wright TB, Shults J, Leonard MB, Zemel BS, Burnham JM: Hypovitaminosis D is associated with greater body mass index and disease activity in pediatric systemic lupus erythematosus. J Pediatr 2009; 155: 260-265.
160. Peroni DG, Piacentini GL, Cametti E, Chinellato I, Boner AL: Correlation between serum 25-hydroxyvitamin D levels and severity of atopic dermatitis in children. Br J Dermatol 2011; 164: 1078-1082.
161. Greer RM, Portelli SL, Hung BS, Cleghorn GJ, McMahon SK, Batch JA, Conwell LS: Serum vitamin D levels are lower in Australian children and adolescents with type1 diabetes than in children without diabetes. Pediatr Diabetes 2013; 14: 31-41.
162. Allen KJ, Koplin JJ, Ponsonby AL, Gurrin LC, Wake M, Vuillermin P, Martin P, Matheson M, Lowe A, Robinson M, Tey D, Osborne NJ, Dang T, Tan HTT, Thiele L, Anderson D, Czech H, Sanjeevan J, Zurzolo G, Dwyer T, Tang MLK, Hill D, Dharmage SC: Vitamin D insufficiency is associated with challenge-proven food allergy in infants. J Allergy Clin Immunol 2013; 131: 1109-1116.